Merck Revenue Boost From Astra Deal Restructuring Is About $680 Mil.
Executive Summary
Merck's restructuring of the Astra joint venture has boosted the company's revenue line by an amount roughly equivalent to the annual sales contribution from the ACE inhibitor Prinivil.